QQ客服 官方微博 反馈留言

	Efficacy and Safety of Nab-Paclitaxel as Second-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer
	Wong, Wenjing; Sun, Ping; Mu, Zhengbin; Liu, Jiannan; Yu, Caiyan; Liu, Aina
刊名	ANTICANCER RESEARCH
	2017
卷号	37期号:8页码:4687-4691
关键词	NSCLC nab-paclitaxel chemotherapy second-line
DOI	10.21873/anticanres.11873
会议名称	China-United Kingdom Cancer (CUKC) Conference
URL标识	查看原文
会议日期	APR 22-23, 2017
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4594843
专题	山东大学
作者单位	1.Shandong Univ, Jinan Cent Hosp, Dept Oncol, Jinan, Shandong, Peoples R China. 2.[Wong, Wenjing 3.Sun, Ping 4.Mu, Zhengbin 5.Liu, Jiannan
推荐引用方式 GB/T 7714	Wong, Wenjing,Sun, Ping,Mu, Zhengbin,et al. Efficacy and Safety of Nab-Paclitaxel as Second-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer[J]. ANTICANCER RESEARCH,2017,37(8):4687-4691.
APA	Wong, Wenjing,Sun, Ping,Mu, Zhengbin,Liu, Jiannan,Yu, Caiyan,&Liu, Aina.(2017).Efficacy and Safety of Nab-Paclitaxel as Second-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer.ANTICANCER RESEARCH,37(8),4687-4691.
MLA	Wong, Wenjing,et al."Efficacy and Safety of Nab-Paclitaxel as Second-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer".ANTICANCER RESEARCH 37.8(2017):4687-4691.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。